Table 3 Secondary outcomes
Variable | Total (N = 140) | 2 L PEG + LB (n = 70) | 4 L PEG (n = 70) | p-value |
|---|---|---|---|---|
Cecal intubation rate, n (%) | 136 (97.1) | 67 (95.7) | 69 (98.6) | 0.21 |
Procedure time (min), median (IQR) | 27 (20–35) | 25 (20–35) | 28.5 (20–35) | 0.52 |
Withdrawal time (min), median (IQR) | 13.5 (10–20) | 14 (9–18) | 13 (10–20) | 0.66 |
Adenoma detection rate, n (%) | 47 (33.6) | 24 (34.3) | 23 (32.9) | 0.86 |
SSP detection rate, n (%) | 6 (4.3) | 3 (4.3) | 3 (4.3) | 0.99 |
HP detection rate, n (%) | 24 (17.1) | 9 (12.9) | 15 (21.4) | 0.18 |
†Proximal adenoma detection rate, n (%) | 19 (13.6) | 11 (15.7) | 8 (11.4) | 0.46 |
‡Distal adenoma detection rate, n (%) | 36 (25.7) | 15 (21.4) | 21 (30) | 0.25 |
Satisfaction score, median (IQR) | 9 (8–10) | 9 (8–10) | 9 (8–10) | 0.08 |
Satisfaction score > 8, n (%) | 124 (88.6) | 64 (91.4) | 60 (85.7) | 0.29 |
Compliance (based on complete ingestion of bowel preparation regimen), n (%) | 138 (98.6) | 70 (100) | 68 (97.1) | 0.50 |
Willingness to repeat the preparation regimen, n (%) | 128 (91) | 66 (94) | 62 (88.6) | 0.37 |
Adverse events, n (%) | 0.89 | |||
None | 102 (72.8) | 50 (71.4) | 52 (74.3) | 0.70 |
Nausea | 28 (20.0) | 16 (22.8) | 12 (17.1) | 0.40 |
Bloating | 5 (3.6) | 2 (2.9) | 3 (4.3) | 0.65 |
Dizziness | 4 (2.9) | 2 (2.9) | 2 (2.9) | 0.99 |
Vomiting | 1 (0.7) | 0 (0) | 1 (1.4) | 0.32 |